Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

  • Bhumsuk Keam1,
  • Seock-Ah Im1, 6Email author,
  • Hee-Jun Kim1,
  • Do-Youn Oh1, 6,
  • Jee Hyun Kim1, 6,
  • Se-Hoon Lee1, 6,
  • Eui Kyu Chie2,
  • Wonshik Han3,
  • Dong-Wan Kim1, 6,
  • Woo Kyung Moon4,
  • Tae-You Kim1, 6,
  • In Ae Park5,
  • Dong-Young Noh3,
  • Dae Seog Heo1, 6,
  • Sung Whan Ha2 and
  • Yung-Jue Bang1, 6
BMC Cancer20077:203

DOI: 10.1186/1471-2407-7-203

Received: 23 May 2007

Accepted: 01 November 2007

Published: 01 November 2007

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 May 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Jul 2007 Reviewed Reviewer Report - Daniela Kandioler
15 Jul 2007 Reviewed Reviewer Report - Frederique Penault-Llorca
15 Aug 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 3
15 Aug 2007 Submitted Manuscript version 3
15 Aug 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 4
15 Aug 2007 Submitted Manuscript version 4
12 Sep 2007 Reviewed Reviewer Report - Frederique Penault-Llorca
25 Sep 2007 Reviewed Reviewer Report - Daniela Kandioler
25 Oct 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 5
25 Oct 2007 Submitted Manuscript version 5
Publishing
1 Nov 2007 Editorially accepted
1 Nov 2007 Article published 10.1186/1471-2407-7-203

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Internal Medicine, Seoul National University College of Medicine
(2)
Department of Radiation Oncology, Seoul National University College of Medicine
(3)
Department of Surgery, Seoul National University College of Medicine
(4)
Department of Radiology, Seoul National University College of Medicine
(5)
Department of Pathology, Seoul National University College of Medicine
(6)
Cancer Research Institute, Seoul National University College of Medicine

Advertisement